Merit Medical (MMSI) CEO Fred Lampropoulos disclosed the sale of 20,000 at an average price of $96.54 for a value of $1.93M. Lampropoulos still owns 1,066,028 shares of Merit Medical.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Positive Outlook for Merit Medical Systems Amid Tariff Reductions and Resilient Growth
- Merit Medical price target raised to $110 from $106 at Piper Sandler
- Merit Medical price target raised to $112 from $108 at Canaccord
- Merit Medical price target raised to $108 from $106 at Wells Fargo
- Merit Medical Acquires Biolife Delaware for $120 Million